ArticleJACC. Case reports2025
Limited-Access Zero-Contrast BASILICA Transcatheter Aortic Valve Replacement.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSevere anaphylactic reactions to intra-arterial contrast agents, access site limitations, and high-risk coronary artery occlusion may all possibly prohibit the success of a transcatheter aortic valve replacement (TAVR). We describe a case including all 3 of these components and demonstrate the importance of multimodality imaging, including computed tomography (CT), fluoroscopy, and trans-esophageal echocardiography (TEE). KEY STEPS: 1) Obtain orthogonal BASILICA angle from CT. 2) Set up a single femoral access for BASILICA and subsequent TAVR. 3) Place a coronary wire with the radial opaque part at the noncoronary cusp (NCC) from an ulnar artery. 4) Perform TEE with fluoroscopic guidance on BASILICA without intra-arterial contrast agent. 5) Use coronary wire as a marker at the NCC to facilitate TAVR deployment. POTENTIAL PITFALLS: A single wire at cusp level minimizes the need to use a multiple pigtail technique. In general, cerebral protection devices are commonly used in leaflet modification procedures such as BASILICA to reduce stroke risk. In view of limited access, it was not feasible in this case to use them. Despite no intra-arterial contrast being used, pre-TAVR CT still requires an intravenous contrast agent for CT planning. TAKE-HOME MESSAGE: In a case of limited access, high coronary occlusive risk, and anaphylactic reaction to contrast agents, a limited-access zero-contrast agent BASILICA TAVR is a feasible approach with the use of multimodality imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.